Momenta and Sandoz on a Roll |
Abstract
pdf
|
Business Review Editor |
|
POZEN Forgets Migraines to Collaborate with AstraZeneca |
Abstract
pdf
|
Business Review Editor |
|
Medicure Takes Over US Marketing of Aggrastat#174; |
Abstract
pdf
|
Business Review Editor |
|
Biopharmaceutical Clusters in Europe: Differences and Similarities |
Abstract
pdf
|
Business Review Editor |
|
Therapy Focus: Atopic Eczema |
Abstract
pdf
|
Business Review Editor |
|
Ipsen and Tercica Enter into Cross-Licensing and Equity Collaboration |
Abstract
pdf
|
Business Review Editor |
|
Predix Licenses S1P1 Modulators to Amgen |
Abstract
pdf
|
Business Review Editor |
|
Apotex’s Confidence Scares Large Pharma |
Abstract
|
Business Review Editor |
|
Lilly and Alcon Eye Success with Treatment for Diabetic Retinopathy |
Abstract
pdf
|
Business Review Editor |
|
Good Cop:Bad Cop in Negotiations |
Abstract
html
|
Fintan Walton |
|
Acquisitions with a Twist |
Abstract
pdf
|
Business Review Editor |
|